Lysandro Pinto Borges

Dr. Lysandro Pinto Borges

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PJPamela Chaves de Jesus
Pamela Chaves de Jesus
DSDeise Maria Rego Rodrigues Silva
Deise Maria Rego Rodrigues Silva
PMPedro Henrique Macedo Moura
Pedro Henrique Macedo Moura
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
ESEloia Emanuelly Dias Silva
Eloia Emanuelly Dias Silva
LBLysandro Pinto Borges
Lysandro Pinto Borges
Background: This review examines in vitro techniques for characterizing the pharmacokinetics of medicinal plants, focusing on their role in understanding absorption, distribution, metabolism, and excretion (ADME). The diverse bioactive compounds in medicinal plants highlight the need for robust pharmacokinetic evaluations to ensure their safety and efficacy. Objectives: The objectives were to identify and analyze in vitro techniques applied to medicinal plants’ pharmacokinetics, addressing a gap in the literature. Methods: Studies were included based on predefined eligibility criteria: in vitro pharmacokinetic studies involving medicinal plants, focusing on ADME stages. Ex vivo, in vivo, and in silico studies were excluded, along with reviews. Data were collected from the PubMed, Web of Science, and Scopus databases in June 2024 using Health Sciences Descriptors (DeCS) and their MeSH synonyms. The data extracted included study location, plant species, bioactive compounds, in vitro protocols, and ADME characteristics. Results: The review included 33 studies, with most focusing on metabolism (60%), absorption (25%), or a combination of ADME aspects. Techniques like Caco-2 cells, human liver microsomes, and simulated gastric and intestinal fluids were widely used. Conclusions: The findings highlight methodological heterogeneity, including variability in extract preparation, compound concentrations, and experimental conditions, which limits the comparability and clinical applicability of results. Key limitations include the lack of standardized protocols and physiological relevance in in vitro models, underscoring the need for multidisciplinary approaches and integration with in vivo studies.

26 April 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
Bruna De Paula DiasBruna De Paula Dias
Bruna De Paula Dias
CBCamila Cavadas Barbosa
Camila Cavadas Barbosa
CFCyntia Ferreira
Cyntia Ferreira
SSSamara Mayra Soares Alves dos Santos
Samara Mayra Soares Alves dos Santos
OAOrlando Alfredo Pineda Arrieta
Orlando Alfredo Pineda Arrieta
Breno Mello SilvaBreno Mello Silva
Breno Mello Silva
Arthropods transmit arboviruses via mosquito and tick bites to humans and other animals. The genus flavivirus, which causes diseases, sequelae, and thousands of deaths, mainly in developing and underdeveloped countries, is among the arboviruses of interest to public health. Given the importance of early and accurate diagnosis, this review analyzes the methods of direct detection of flaviviruses, such as reverse transcription loop-mediated isothermal amplification, microfluidics, localized surface plasmon resonance, and surface-enhanced Raman scattering, and presents the advantages, disadvantages, and detection limits identified in studies reported in the literature for each methodology. Among the different methods available, it is essential to balance four fundamental indicators to determine the ideal test: good sensitivity, high specificity, low false positive rate, and rapid results. Among the methods analyzed, reverse transcription loop-mediated isothermal amplification stands out, owing to result availability within a few minutes, with good sensitivity and specificity; in addition, it is the best-characterized methodology.

4 March 2024 in Life
Verified
Journal Article
Open access
PDF file
AJAilton Santos Sena Júnior
Ailton Santos Sena Júnior
Felipe J. AidarFelipe J. Aidar
Felipe J. Aidar
LSLuiz A. S. Silva
Luiz A. S. Silva
TSThais de B. Silva
Thais de B. Silva
SASara F. M. de Almeida
Sara F. M. de Almeida
ALAna A. M. Lira
Ana A. M. Lira
(1) Background: Species of the genus Cymbopogon and its essential oil are known for their antioxidant and hypoglycemic effects. This study aimed to investigate the impact of the essential oil of Cymbopogon flexuosus (EOCF), and its major component, citral, on glycemic, lipid, antioxidant parameters, and oxidative stress in a type 1 diabetes (DM1) rat model. (2) Methods: Initially, EOCF was analyzed by Gas chromatography-mass spectrometry (GC-MS) and the antioxidant activity of EOCF and citral was evaluated. Next, male Wistar rats (3 months old, 200–250 g) induced with DM1 using Streptozotocin (STZ) were divided into four groups: negative control supplemented with an 80% Tween solution, two groups of animals supplemented with EOCF (32 mg/kg and 64 mg/kg) and with citral (32 mg/kg), and treated for 14 days. Measurements of blood glucose levels and body weight were taken; after euthanasia, biochemical markers, including lipid profile, uric acid, alanine aminotransferase (ALT), and aspartate aminotransferase (AST), were evaluated. (3) Results: The predominant compounds in EOCF were α-citral (53.21%) and neral (19.42%), constituting 72.63% citral. EOCF showed good antioxidant activity, significantly greater than citral. EOCF supplementation demonstrated a mitigating effect on glycemic, lipid, and hepatic abnormalities induced by DM1. (4) Conclusions: EOCF emerges as a promising therapeutic option for the management of DM1.

1 May 2021 in Journal of Infection
Verified
Journal Article
Closed access
RGRicardo Queiroz Gurgel
Ricardo Queiroz Gurgel
LSLaís Catarine de Sá
Laís Catarine de Sá
DSDaniela Raguer Valadão Souza
Daniela Raguer Valadão Souza
AMAline Fagundes Martins
Aline Fagundes Martins
IMIgor Leonardo Santos Matos
Igor Leonardo Santos Matos
LBLysandro Pinto Borges
Lysandro Pinto Borges

7 March 2024 in Oral Oncology
Verified
Journal Article
Closed access
LSLucas Santana
Lucas Santana
LFLara Góis Floresta
Lara Góis Floresta
ÊAÊmilly Victória Maciel Alves
Êmilly Victória Maciel Alves
LMLucas Morais Rodrigues Melo
Lucas Morais Rodrigues Melo
RFRamomm Rocha Tavares Ferreira
Ramomm Rocha Tavares Ferreira
LBLysandro Pinto Borges
Lysandro Pinto Borges

26 May 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
AMAline Fagundes Martins
Aline Fagundes Martins
DSDaniela Raguer Valadão de Souza
Daniela Raguer Valadão de Souza
JNJosé Melquiades de Rezende Neto
José Melquiades de Rezende Neto
ASAryanne Araujo Santos
Aryanne Araujo Santos
GIGrazielly Bispo da Invenção
Grazielly Bispo da Invenção
LBLysandro Pinto Borges
Lysandro Pinto Borges
The historical and social vulnerability of quilombola communities in Brazil can make them especially fragile in the face of COVID-19, considering that several individuals have precarious health systems and inadequate access to water. This work aimed to characterize the frequency of SARS-COV-2 infections and the presence of IgM and IgG SARS-CoV-2 antibodies in quilombola populations and their relationship with the presence of risk factors or preexisting chronic diseases in the quilombola communities. We analyzed the sociodemographic and clinical characteristics, serological status, comorbidities, and symptoms of 1,994 individuals (478 males and 1,536 females) from 18 Brazilian municipalities in the State of Sergipe of quilombola communities, which were evaluated at different epidemiological weeks, starting at the 32nd (August 6th) and ending at the 40th (October 3rd) epidemiological week. More than 70% of studied families live in rural areas and they have an extreme poverty social status. Although we found a higher number of SARS-COV-2 infections in quilombola communities than in the local population, their SARS-CoV-2 reactivity and IgM and IgG positivity varied across the communities investigated. Arterial hypertension was the most risk factor, being found in 27.8% of the individuals (9.5% in stage 1, 10.8% in stage 2, and 7.5% in stage 3). The most common COVID-19 symptoms and comorbidities were headache, runny nose, flu, and dyslipidemia. However, most individuals were asymptomatic (79.9%). Our data indicate that mass testing must be incorporated into public policy to improve the health care system available to quilombola populations during a future pandemic or epidemic.